Skip to main content

Table 1 Baseline characteristics of the study population

From: Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial

 

Pen group

Syringe group

(p value)

Age in years (mean ± SD)

64.43 ± 12.60

67.68 ± 5.09

0.660

Male sex (%)

37.7

33.34

0.171

Race (%)

 Caucasian

60.6

70

0.083

 African-descendant

6.6

13.3

 Others

32.8

16.7

Religion (%)

 Catolics

70.4

61.7

0.161

 Evangelic

19.7

20.0

 Spiritualists

6.60

5.00

 Others

3.30

13.3

Family income*(%)

 Up to 1 minimum wage

11.4

15

0.199

 1–2 minimum wage

44.3

58.3

 Over 2 minimum wages

44.3

26.7

Education level in years (%)

 Uneducated or less than 1 year

8.2

11.7

0.753

 1 to 3 years

16.4

13.2

 4 to 8 years

45.9

51.7

 9 years or more

29.5

23.4

History of smoking (%)

 Never smoking

57.4

66.6

0.364

 Current smoking

1.60

3.40

 Former

41.0

30.0

Alcohol consumption (%)

 Never drinking

54.1

55.0

0.999

 Social considers

27.9

26.7

 Alcohol abusers

1.60

1.70

 former

16.4

16.6

Diabetic Retinopathya n and (%)

 Absent

32/50 (64.0)

35/49 (71.4)

0.536

 Mild or moderative, non proliferative

9/50 (18.0)

8/49 (16.3)

 Severe, non proliferative

2/50 (4.00)

−(0.00)

Proliferative

7/50 (14.0)

6/49 (12.3)

Diabetic Nephropathyb n and (%)

 Absent

28/51 (54.9)

30/59 (50.8)

0.088

 Albuminuria increased

15/51 (29.4)

21/59 (35.6)

 Albuminuria greatly increased

6/51 (11.8)

8/59 (13.6)

 Nephrotic albuminuria

2/51 (3.90)

−(0.00)

Presence of diabetic neuropathyb n and (%)

13/49 (26.5)

21/53 (39.6)

0.413

Presence of cerebrovascular diseasec n and (%)

13/58 (22.4)

5/56 (8.90)

0.077

Presence of ischemic cardiopathyd n and (%)

17/57 (29.9)

15/60 (25.0)

0.353

Time of diabetes in years (mean ± SD)

16.89 ± 9.64

17.83 ± 9.45

0.589

Time using insulin in years (mean ± SD)

8.89 ± 8,94

8.22 ± 8.73

0.686

Glycated hemoglobin (mean ± SD)

10.34 ± 1.66

9.90 ± 1.25

0.103

Familial history of type 2 diabetes n and (%)

47/61 (77.0)

43/60 (71.7)

0.537

Presence of hypertension n and (%)

57/61 (93.4)

53/60 (88.3)

0.464

Number of antihyperglycemic agents (mean ± SD)

2.8 ± 1.54

2.58 ± 1.32

0.409

Classes of antihyperglycemic agents (mean ± SD)

1.17 ± 0.49

1.47 ± 0.62

0.050

Time of Hypertension in years (mean ± SD)

17.07 ± 8.36

14.67 ± 8.87

0.148

Number of used drugs (mean ± SD)

7.66 ± 2.21

7.52 ± 2.38

0.721

Number of antihypertensives (mean ± SD)

2.80 ± 1.54

2.58 ± 1.32

0.409

Number of use tablet (mean ± SD)

12.24 ± 4.73

11.62 ± 4.93

0.625

Insulin dose per kg/day (mean ± SD)

0.76 ± 0.33

0.63 ± 0.39

0.056

BMI (Kg/m2) (mean ± SD)

31.35 ± 4.35

31.53 ± 5.03

0.830

Systolic blood pressure in mmHg (mean ± SD)

139.05 ± 15.62

133.46 ± 18.22

0.072

Diastolic blood pressure in mmHg (mean ± SD)

79.16 ± 12.37

73.72 ± 11.03

0.012

  1. *minimum wage equal to $ 220.70 (reference year = august/2015)
  2. achart review
  3. bchart review; we consider albuminuria > 14 mg/g of creatinine (albuminuria increased) and > 140 mg/g of creatinine (albuminuria great increased), and neuropathy to patients with description of positive monofilament test, sensorial changes or suggestive lesions
  4. chistory of transient ischemic attack or stroke
  5. dhistory of unstable angina, acute myocardial infarction or diagnosis of ischemic heart disease